Sounding board. Unapproved drugs in the practice of medicine.
作者信息
Franklin W, Lowell F C
出版信息
N Engl J Med. 1975 May 15;292(20):1075-7. doi: 10.1056/NEJM197505152922010.
PMID:1124091
Abstract
摘要
相似文献
1
Sounding board. Unapproved drugs in the practice of medicine.
N Engl J Med. 1975 May 15;292(20):1075-7. doi: 10.1056/NEJM197505152922010.
2
Present attitudes of governmental drug regulatory agencies.政府药品监管机构目前的态度。
Int J Clin Pharmacol. 1973 Apr;7(2):168-77.
3
Sounding board. Creative tension: FDA and medicine.共鸣板。创造性张力：美国食品药品监督管理局与医学。
N Engl J Med. 1978 Apr 13;298(15):846-50. doi: 10.1056/NEJM197804132981511.
4
The case for deregulating drug efficacy.
JAMA. 1979 Oct 19;242(16):1755-60.
5
Primum non nocere.首要的是不伤害。
JAMA. 1977 Aug 15;238(7):589-90.
6
Approved drugs for unapproved indications: some clouds on the horizon.已批准药物用于未批准适应症：前景有些阴霾。
J Am Acad Dermatol. 1992 Jul;27(1):133-5. doi: 10.1016/s0190-9622(08)80830-4.
7
The FDA takes action against unapproved drugs.美国食品药品监督管理局对未经批准的药品采取行动。
FDA Consum. 2007 Jan-Feb;41(1):34-5.
8
Restrictions on clinical research.临床研究的限制。
Eur J Clin Pharmacol. 1974 Oct 4;7(6):479. doi: 10.1007/BF00560362.
9
Balancing risks versus benefits in drug therapy decisions.
Clin Ther. 1998;20 Suppl C:C72-9. doi: 10.1016/s0149-2918(98)80010-6.
10
Sounding board. How the proposed Drug Regulation Reform Act will discourage the search for new drugs.共鸣板。拟议的《药品监管改革法案》将如何阻碍新药研发。
N Engl J Med. 1978 Aug 24;299(8):413-5. doi: 10.1056/NEJM197808242990809.
Zotero 插件